Lista de obras -

A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women.

artículo científico publicado en 2015

Beyond contraception and hormone replacement therapy: advancing Nestorone to a neuroprotective drug in the clinic

artículo científico publicado en 2018

Bone turnover markers in women participating in a dose-finding trial of a contraceptive vaginal ring releasing Nestorone and estradiol

artículo científico publicado en 2019

Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.

artículo científico publicado en 2017

Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men

scientific article published on 10 April 2019

Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study

artículo científico publicado en 2018

Effects of a One Year Reusable Contraceptive Vaginal Ring on Vaginal Microflora and the Risk of Vaginal Infection: An Open-Label Prospective Evaluation.

artículo científico publicado en 2015

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

scientific article published on 20 June 2019

Hormonal contraception and thrombosis.

artículo científico publicado en 2016

Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial.

artículo científico publicado en 2017

Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.

artículo científico publicado en 2015

It is time for new male contraceptives!

artículo científico publicado en 2016

Nestorone<sup>®</sup> , a 19nor-progesterone derivative boosts remyelination in an animal model of demyelination

artículo científico publicado en 2020

Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies.

artículo científico publicado en 2016

Neurosteroidogenesis and progesterone anti-inflammatory/ neuroprotective effects

artículo científico publicado en 2017

Non-clinical studies of progesterone

scientific article published on 23 May 2018

OR33-5 Low Systemic Levels of Segesterone Acetate are Required to Inhibit Ovulation in Women

Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel

artículo científico publicado en 2018

Reprint of: Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic

scientific article published on 15 June 2019

SAT-219 A Novel 1-Year Contraceptive Vaginal System Delivering Segesterone Acetate and Ethinyl Estradiol: Effects on Lipids and other Hepatic Proteins

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

artículo científico publicado en 2019

The Paris Manifesto: It's time for new male contraceptives

artículo científico publicado en 2016

The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration.

artículo científico publicado en 2015

Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain

scientific article published on 01 October 2018

[Estrogen, hormonal therapy and Aging].

artículo científico publicado en 2015

Lista de obras de

A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women.

Beyond contraception and hormone replacement therapy: advancing Nestorone to a neuroprotective drug in the clinic

Bone turnover markers in women participating in a dose-finding trial of a contraceptive vaginal ring releasing Nestorone and estradiol

Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.

Combined nestorone-testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men

Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study

Effects of a One Year Reusable Contraceptive Vaginal Ring on Vaginal Microflora and the Risk of Vaginal Infection: An Open-Label Prospective Evaluation.

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials

Hormonal contraception and thrombosis.

Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial.

Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.

It is time for new male contraceptives!

Nestorone<sup>®</sup> , a 19nor-progesterone derivative boosts remyelination in an animal model of demyelination

Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies.

Neurosteroidogenesis and progesterone anti-inflammatory/ neuroprotective effects

Non-clinical studies of progesterone

OR33-5 Low Systemic Levels of Segesterone Acetate are Required to Inhibit Ovulation in Women

Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel

Reprint of: Beyond contraception and hormone replacement therapy: Advancing Nestorone to a neuroprotective drug in the clinic

SAT-219 A Novel 1-Year Contraceptive Vaginal System Delivering Segesterone Acetate and Ethinyl Estradiol: Effects on Lipids and other Hepatic Proteins

Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation

The Paris Manifesto: It's time for new male contraceptives

The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration.

Therapeutic progestin segesterone acetate promotes neurogenesis: implications for sustaining regeneration in female brain

[Estrogen, hormonal therapy and Aging].